Comerica: Financial Winner
Looking for a high payout ratio following stress tests.
Comerica's shares have now returned 17% year-to-date, following a 38% decline during 2011.
The shares trade for 0.9 times book value, according to Thomson Reuters Financial Insight, and for 11 times the consensus 2013 EPS estimate of $2.63. The consensus 2014 EPS estimate is $2.77.
Based on a quarterly payout of 15 cents Comerica's shares have a dividend yield of 2.01%. Following the last round of Federal Reserve stress tests in March, the company was approved to repurchase up to $375 million worth of common shares, through the first quarter of 2013. Including shares repurchased as part of deferred compensation plans, Comerica bought back $215.5 million worth of shares during the first three quarters of 2012.
Bank of America Merrill Lynch analyst Erika Penala on Monday estimated that following the next round of stress tests, Comerica will be approved to raise the quarterly dividend by a penny and buy back another $321 million worth of shares, which would give the company a combined payout ratio of 101% during 2013.
While being approved to pay out more of its earnings would certainly signal regulators' comfort with the company's capital strength, Bank of America Merrill Lynch still has a "Neutral" rating on Comerica. Penala said that "while buying back stock in a [tangible book value, or TBV] accretive manner is a positive (TBV was $33.63 in 3Q12), a challenged return outlook (we forecast average ROTE of 7% over the next two years) is likely to temper valuations and stock performance as CMA struggles to earn its cost of equity in a low rate environment."
CMA data by YChartsInterested in more on Comerica? See TheStreet Ratings' report card for this stock.
-- Written by Philip van Doorn in Jupiter, Fla. >Contact by Email. Follow @PhilipvanDoorn
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV